# 72 FR 262: Oral Dosage Form New Animal Drugs; Dirlotapide

> Federal · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22542

## Section

- **Citation:** 72 FR 262
- **Heading:** Oral Dosage Form New Animal Drugs; Dirlotapide
- **Jurisdiction:** Federal
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** September 30, 2026
- **Source:** Compiled text
- **Location:** Federal Register / Vol. 72 / 72 FR 262

## Text

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 520 Oral Dosage Form New Animal Drugs; Dirlotapide AGENCY:
Food and Drug Administration, HHS.

ACTION:
Final rule.

SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pfizer, Inc. The NADA provides for the veterinary prescription use of dirlotapide solution in dogs for the management of obesity.

DATES:
This rule is effective January 4, 2007.

FOR FURTHER INFORMATION CONTACT:
Melanie R. Berson, Center for Veterinary Medicine (HFV-110), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-7540, e-mail: melanie.berson@fda.hhs.gov .

SUPPLEMENTARY INFORMATION:
Pfizer, Inc., 235 East 42d St., New York, NY 10017-5755, filed NADA 141-260 for SLENTROL (dirlotapide) Oral Solution. The NADA provides for the veterinary prescription use of dirlotapide solution in dogs for the management of obesity. The application is approved as of December 12, 2006, and the regulations are amended in 21 CFR part 520 by adding new § 520.666 to reflect the approval. The basis of approval is discussed in the freedom of information summary.
In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
Under section 512(c)(2)(F)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(i)), this approval qualifies for 5 years of
The agency has determined under 21 CFR 25.33(d)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 520
Animal drugs.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows:
PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 520 continues to read as follows:
Authority:
21 U.S.C. 360b.
2. Section 520.666 is added to read as follows:
§ 520.666 Dirlotapide.
(a) Specifications . Each milliliter (mL) of solution contains 5 milligrams (mg) dirlotapide.
(b) Sponsor . See No. 000069 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs —(1) Amount . The initial dosage is 0.01 mL/kg (0.0045 mL/lb) body weight for the first 14 days. After the first 14 days of treatment, the dose volume is doubled to 0.02 mL/kg (0.009 mL/lb) body weight for the next 14 days (days 15 to 28 of treatment). Dogs should be weighed monthly and the dose volume adjusted every month, as necessary, to maintain a target percent weight loss until the desired weight is achieved.
(2) Indications for use . For the management of obesity.
(3) Limitations . Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dated: December 20, 2006. Stephen F. Sundlof, Director, Center for Veterinary Medicine.

[FR Doc. E6-22542 Filed 1-3-07; 8:45 am] BILLING CODE 4160-01-S

## Nearby sections

- [72 FR 11 Approval and Promulgation of Implementation Plans; Revisions to the Nevada State Implementation Plan; Requests for Rescission](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22408.md)
- [72 FR 247 Tuberculosis in Cattle and Bison; State and Zone Designations; Texas](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22545.md)
- [72 FR 262 Oral Dosage Form New Animal Drugs; Florfenicol](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22516.md)
- [72 FR 262 Oral Dosage Form New Animal Drugs; Dirlotapide](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22542.md)
- [72 FR 263 Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22508.md)
- [72 FR 264 Implantation or Injectable Dosage Form New Animal Drugs; Atipamezole](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22515.md)
- [72 FR 269 Changes in Flood Elevation Determinations](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22523.md)
- [72 FR 272 Final Flood Elevation Determinations](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22521.md)
- [72 FR 368 Unregulated Contaminant Monitoring Regulation (UCMR) for Public Water Systems Revisions](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22123.md)
- [72 FR 647 Airworthiness Directives; Boeing Model 707-100 Long Body, -100B Long Body, -100B Short Body, -E3F, -300, -300B, and -300C Series Airplanes; Model 727-100 and -200 Series Airplanes; Model 737-200, -200C, -300, -400, and -500 Series Airplanes; Model 747-100B, 747-200B, 747-200C, 747-200F, 747-300, 747-400, 747-400D, 747SR, and 747SP Series Airplanes; Model 757-200 and 757-200PF Series Airplanes; and Model 767-200 and -300 Series Airplanes; Equipped With Observer or Attendant Seats](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22467.md)
- [72 FR 653 Approval and Promulgation of Air Quality Implementation Plans; Virginia; Identification of the Northern Virginia PM2.5 Nonattainment Area](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22552.md)
- [72 FR 902 Qualified Amended Returns](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22645.md)
- [72 FR 1135 Mediterranean Fruit Fly; Remove Portions of Los Angeles, San Bernardino, and Santa Clara Counties, CA, From the List of Quarantined Areas](https://www.frixlaw.com/law-library/statutes/FR_RULE_E7-110.md)
- [72 FR 1141 Airworthiness Directives; Turbomeca Artouste III B and III B1 Turboshaft Engines](https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22533.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/FR_RULE_E6-22542. Check the current official text before relying on it. Not legal advice.
